leadf
logo-loader
RNS
viewNMC Health PLC

FTSE Russell - NMC Health

RNS Number : 9505J
FTSE Russell
16 April 2020
 

 

 


 

 

NMC Health (UK): Treatment in FTSE Russell Indexes - Update

16 April 2020

Further to the FTSE Russell notice released on 09 April 2020, regarding the appointment of administrators to NMC Health (UK, B7FC076, FTSE 100 Index, GEIS Mid Cap), FTSE Russell hereby notifies index users that, absent any change to the company's situation or a confirmation from the London Stock Exchange of the company's delisting beforehand, FTSE Russell intends to remove NMC Health from FTSE Russell indexes using a nominal value at the expiry of the 40 day suspension period (i.e. effective from the open of Monday 27 April 2020).

NMC Health is currently valued at the price of 111.63 GBX which was the price of the ADR traded OTC as at Thursday 12 March 2020.  As the shares of NMC Health can no longer be converted into the ADR, the OTC price can no longer be obtained and the price of NMC Health in FTSE Russell indexes will be set to the nominal value of 0.0001 GBX with effect from UK market close tonight.

 

 

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

                                   

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FTSKKABPABKDOQD

Quick facts: NMC Health PLC

Price: -

Market: LSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read